Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2066153
Reference Type
Journal Article
Title
Neutralizing capacity and cost effectiveness of antacids
Author(s)
Drake, D; Hollander, D
Year
1981
Is Peer Reviewed?
Yes
Journal
Annals of Internal Medicine
ISSN:
0003-4819
EISSN:
1539-3704
Report Number
IPA/81/444089
Volume
Intern
Issue
REF 5
Page Numbers
215-217
Language
eng
Abstract
IPA COPYRIGHT: ASHP Commonly available antacids, both liquid and tablet, were tested for their acid neutralizing capacity; the cost of one month of therapy was tabulated and the cost effectiveness calculated. The acid neutralizing capacity and cost effectiveness of liquid antacids are generally better than tablet antacids. The most effective liquid antacids, which are composed of either aluminum and magnesium hydroxide mixtures or calcium carbonate, vary in buffering capacity from 3 to 4.2 meq/ml of antacid and range in monthly cost of therapy from $35 to $74. The 3 most effective liquid antacids were Maalox TC (aluminum hydroxide and magnesium hydroxide; monthly cost of $44), Titralac (calcium carbonate and glycine (aminoacetic acid); monthly cost of $35) and Delcid (aluminum hydroxide and magnesium hydroxide; monthly cost of $57). In contrast, the 5 least effective liquid antacids vary in acid neutralizing capacity from 0.3 to 2.3 meq/ml of antacid and in monthly cost of therapy from $78 to $498. Because the cost of therapy is influenced primarily by the acid neutralizing capacity, prescription of a high potency antacid is suggested, and the taste and sodium content of the antacids taken into account.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity